High-Volume Hemodiafiltration Remains the Benchmark for Survival Evidence in Dialysis
June 10, 2026
June 10, 2026
HOMBURG, Germany, June 10 (TNSxrep) -- Fresenius Medical Care, a provider of products and services for people with chronic kidney failure, issued the following news release:
* * *
High-Volume Hemodiafiltration Remains the Benchmark for Survival Evidence in Dialysis
At the recent European Renal Association (ERA) Congress in Glasgow, researchers presented updated results from the Spanish MOTheR study./1
While the study adds information to a growi . . .
* * *
High-Volume Hemodiafiltration Remains the Benchmark for Survival Evidence in Dialysis
At the recent European Renal Association (ERA) Congress in Glasgow, researchers presented updated results from the Spanish MOTheR study./1
While the study adds information to a growi . . .